Michael D West - Net Worth and Insider Trading
Michael D West Net Worth
The estimated net worth of Michael D West is at least $450,730 dollars as of 2024-12-27. Michael D West is the Co-CEO of Lineage Cell Therapeutics Inc and owns about 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $445,846. Michael D West is also the CEO of AgeX Therapeutics Inc and owns about 440 shares of AgeX Therapeutics Inc (AGE) stock worth over $4,884. Details can be seen in Michael D West's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael D West has not made any transactions after 2018-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael D West
Michael D West Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D West owns 5 companies in total, including AgeX Therapeutics Inc (AGE) , Lineage Cell Therapeutics Inc (LCTX) , and OncoCyte Corp (OCX) among others .
Click here to see the complete history of Michael D West’s form 4 insider trades.
Insider Ownership Summary of Michael D West
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AGE | AgeX Therapeutics Inc | 2018-12-10 | director & Chief Executive Officer |
LCTX | Lineage Cell Therapeutics Inc | 2017-08-22 | director |
OCX | OncoCyte Corp | 2015-12-30 | director |
2015-02-13 | director & VP of Technology Integration | ||
2007-10-09 | director |
Michael D West Latest Holdings Summary
Michael D West currently owns a total of 2 stocks. Among these stocks, Michael D West owns 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 22, 2017, with a value of $445,846 and a weighting of 98.92%. Michael D West also owns 440 shares of AgeX Therapeutics Inc (AGE) as of December 10, 2018, with a value of $4,884 and a weighting of 1.08%.
Latest Holdings of Michael D West
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics Inc | 2017-08-22 | 882,864 | 0.51 | 445,846 |
AGE | AgeX Therapeutics Inc | 2018-12-10 | 440 | 11.10 | 4,884 |
Holding Weightings of Michael D West
Michael D West Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 2,000 shares on August 22, 2017, which cost Michael D West around $5,200.
According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in AgeX Therapeutics Inc (AGE) over the past 5 years. The most-recent trade in AgeX Therapeutics Inc is the acquisition of 114 shares on December 10, 2018, which cost Michael D West around $15,440.
Insider Trading History of Michael D West
- 1
Michael D West Trading Performance
GuruFocus tracks the stock performance after each of Michael D West's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D West is 1.87%. GuruFocus also compares Michael D West's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D West within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael D West's insider trading performs compared to the benchmark.
Performance of Michael D West
Michael D West Ownership Network
Michael D West Owned Company Details
What does AgeX Therapeutics Inc do?
Who are the key executives at AgeX Therapeutics Inc?
Michael D West is the director & Chief Executive Officer of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and Chief Financial Officer Russell Skibsted .
AgeX Therapeutics Inc (AGE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
AgeX Therapeutics Inc Insider Transactions
Michael D West Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D West. You might contact Michael D West via mailing address: Agex Therapeutics, Inc., 1101 Marina Village Parkway, Suite 201, Alameda Ca 94501.